A Phase III Study Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL

Conditions: ETP-ALL Interventions: Drug: Homoharringtonine; Drug: venetoclax; Drug: Cytarabine; Drug: G-CSF; Drug: Vindesine; Drug: Daunorubicin; Drug: cyclophosphamide; Drug: Dexamethasone; Drug: L-ASP Sponsors: First Affiliated Hospital of Zhejiang University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials